Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...
From Nov. 17, Viatris will be the surviving company formed by the combination of leading generic maker Mylan and Upjohn, Pfizer's generics business. The new entity will continue to focus on the prior ...
WASHINGTON—The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results